Insider Shareholders with Direct Ownership of Celldex Therapeutics, Inc. (CLDX)
This section provides a comprehensive overview of the insiders with direct ownership of Celldex Therapeutics, Inc. (CLDX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Celldex Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Freddy A. Jimenez
SVP & GENERAL COUNSEL |
42,142 | 8,006 | 35,464 $1.54 Million | 5 |
Jun 05, 2024
Added 21.2%
|
Samuel Bates Martin
SVP AND CFO |
111,300 | 93,910 | 28,125 $1.22 Million | 15 |
Jun 14, 2024
Reduced 37.91%
|
Anthony S Marucci
PRESIDENT & CEO |
123,537 | 120,000 | 27,692 $1.2 Million | 3 |
Aug 15, 2022
Reduced 81.25%
|
Richard M. Wright
SR. VP & CCO |
103,629 | 83,004 | 20,833 $905,610 | 6 |
Jun 03, 2024
Reduced 48.04%
|
Diane C. Young
SVP, CHIEF MEDICAL OFFICER |
83,600 | 68,600 | 17,115 $743,989 | 6 |
Jun 11, 2024
Added 46.71%
|
Margo Heath Chiozzi
SVP OF REGULATORY AFFAIRS |
109,577 | 98,288 | 13,383 $581,759 | 9 |
Jun 03, 2024
Reduced 81.35%
|
Elizabeth Crowley
SR. VP & CPDO |
100,500 | 91,914 | 9,074 $394,446 | 10 |
Jun 14, 2024
Reduced 76.78%
|
Tibor Keler
EXECUTIVE VP & CSO |
16,860 | 16,860 | 7,357 $319,808 | 2 |
Dec 07, 2022
Reduced 69.62%
|
Sarah Cavanaugh
SVP OF CORP AFFAIRS & ADMIN. |
66,799 | 68,166 | 1,860 $80,854 | 10 |
May 30, 2024
Reduced 91.81%
|